{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T23:29:24Z","timestamp":1793489364261,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejphar.2026.179466","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:02:01Z","timestamp":1792796521000},"page":"179466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Resolving the dual nature of NADPH oxidase 4 in cardiac fibrosis for selective therapeutic targeting: A narrative review"],"prefix":"10.1016","volume":"1038","author":[{"given":"Drashti","family":"Prajapati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasanjit","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.179466_bib1","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1161\/CIRCRESAHA.109.213116","article-title":"Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes","volume":"106","author":"Ago","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2026.179466_bib2","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1007\/s00018-012-1010-9","article-title":"The NOX toolbox: validating the role of NADPH oxidases in physiology and disease","volume":"69","author":"Altenh\u00f6fer","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejphar.2026.179466_bib3","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.freeradbiomed.2011.11.023","article-title":"NOX5: from basic biology to signaling and disease","volume":"52","author":"Bedard","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2026.179466_bib4","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2019103530","article-title":"Nox4 regulates InsP3 receptor\u2010dependent Ca2+ release into mitochondria to promote cell survival","volume":"39","author":"Beretta","year":"2020","journal-title":"EMBO J."},{"key":"10.1016\/j.ejphar.2026.179466_bib5","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.4103\/1673-5374.390973","article-title":"NADPH oxidase 4 (NOX4) as a biomarker and therapeutic target in neurodegenerative diseases","volume":"19","author":"Boonpraman","year":"2024","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.ejphar.2026.179466_bib6","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1124\/pr.120.019422","article-title":"On the clinical pharmacology of reactive oxygen species","volume":"72","author":"Casas","year":"2020","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2026.179466_bib7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11010-025-05400-1","article-title":"Unraveling the interplay between RAS axes and NOX signaling in fibroblasts during cardiac fibrosis","volume":"481","author":"Chaturvedi","year":"2025","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ejphar.2026.179466_bib8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/antiox6020042","article-title":"The role of NOX4 and TRX2 in angiogenesis and their potential cross-talk","volume":"6","author":"Chen","year":"2017","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejphar.2026.179466_bib9","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1161\/01.RES.0000187457.24338.3D","article-title":"NAD(P)H oxidase 4 mediates transforming growth Factor-\u03b21\u2013Induced differentiation of cardiac fibroblasts into myofibroblasts","volume":"97","author":"Cucoranu","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2026.179466_bib10","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.freeradbiomed.2019.12.038","article-title":"Isoform-selective NADPH oxidase inhibitor panel for pharmacological target validation","volume":"148","author":"Dao","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2026.179466_bib11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/164_2020_387","article-title":"NOX inhibitors: from bench to naxibs to bedside","volume":"264","author":"Elbatreek","year":"2021","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179466_bib12","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.tem.2019.02.006","article-title":"Reactive oxygen comes of age: mechanism-based therapy of diabetic end-organ damage","volume":"30","author":"Elbatreek","year":"2019","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.ejphar.2026.179466_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000885","article-title":"NOX5-induced uncoupling of endothelial NO synthase is a causal mechanism and theragnostic target of an age-related hypertension endotype","volume":"18","author":"Elbatreek","year":"2020","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ejphar.2026.179466_bib14","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1089\/ars.2014.6238","article-title":"NOX4 in mitochondria: yeast two-hybrid-based interaction with complex I without relevance for basal reactive oxygen species?","volume":"23","author":"Hirschh\u00e4user","year":"2015","journal-title":"Antioxid. Redox Signaling"},{"key":"10.1016\/j.ejphar.2026.179466_bib15","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/liv.15596","article-title":"Setanaxib, a first\u2010in\u2010class selective NADPH oxidase 1\/4 inhibitor for primary biliary cholangitis: a randomized, placebo\u2010controlled, phase 2 trial","volume":"43","author":"Invernizzi","year":"2023","journal-title":"Liver Int."},{"key":"10.1016\/j.ejphar.2026.179466_bib16","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0891-5849(01)00828-0","article-title":"Overestimation of NADH-driven vascular oxidase activity due to lucigenin artifacts","volume":"32","author":"Janiszewski","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2026.179466_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2021.110123","article-title":"Backstage players of fibrosis: NOX4, mTOR, HDAC, and S1P; companions of TGF-\u03b2","volume":"87","author":"Jim\u00e9nez-Uribe","year":"2021","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejphar.2026.179466_bib18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13075-025-03705-6","article-title":"Inhibition of NOX4 attenuates muscle damage and mitochondrial dysfunction in inflammatory myopathy","volume":"28","author":"Kang","year":"2025","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ejphar.2026.179466_bib19","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1089\/ars.2013.5607","article-title":"NADPH oxidases in vascular pathology","volume":"20","author":"Konior","year":"2014","journal-title":"Antioxid. Redox Signaling"},{"key":"10.1016\/j.ejphar.2026.179466_bib20","doi-asserted-by":"crossref","first-page":"15565","DOI":"10.1073\/pnas.1002178107","article-title":"NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart","volume":"107","author":"Kuroda","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.ejphar.2026.179466_bib21","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/CIRCRESAHA.120.316738","article-title":"KLF5 is induced by FOXO1 and causes oxidative stress and diabetic cardiomyopathy","volume":"128","author":"Kyriazis","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2026.179466_bib22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12933-019-0816-2","article-title":"SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart","volume":"18","author":"Li","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ejphar.2026.179466_bib23","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1172\/JCI85624","article-title":"Tyrosine kinase FYN negatively regulates NOX4 in cardiac remodeling","volume":"126","author":"Matsushima","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2026.179466_bib24","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.3390\/antiox11061069","article-title":"Yin and Yang of NADPH oxidases in myocardial ischemia-reperfusion","volume":"11","author":"Matsushima","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejphar.2026.179466_bib25","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.freeradbiomed.2025.04.046","article-title":"NOX4-driven mitochondrial oxidative stress in aging promotes myocardial remodeling and increases susceptibility to ventricular tachyarrhythmia","volume":"235","author":"Mondragon","year":"2025","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2026.179466_bib26","doi-asserted-by":"crossref","DOI":"10.1007\/s10741-022-10279-x","article-title":"Treatment of cardiac fibrosis: from neuro-hormonal inhibitors to CAR-T cell therapy","author":"Morfino","year":"2022","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.ejphar.2026.179466_bib27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10741-010-9186-2","article-title":"NADPH oxidases and cardiac remodelling","volume":"16","author":"Nabeebaccus","year":"2011","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.ejphar.2026.179466_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102851","article-title":"NOX family NADPH oxidases in mammals: evolutionary conservation and isoform-defining sequences","volume":"66","author":"Nazari","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejphar.2026.179466_bib29","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1021\/bi500331y","article-title":"Nox4: a hydrogen peroxide-generating oxygen sensor","volume":"53","author":"Nisimoto","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejphar.2026.179466_bib30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.freeradbiomed.2016.11.019","article-title":"Cytochrome P450 enzymes but not NADPH oxidases are the source of the NADPH-dependent lucigenin chemiluminescence in membrane assays","volume":"102","author":"Rezende","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2026.179466_bib31","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1089\/ars.2015.6393","article-title":"Antioxidants in translational medicine","volume":"23","author":"Schmidt","year":"2015","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.ejphar.2026.179466_bib32","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1161\/CIRCRESAHA.113.301787","volume":"113","author":"Sciarretta","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2026.179466_bib33","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/jcp.25210","article-title":"The Nox1\/4 dual inhibitor GKT137831 or Nox4 Knockdown inhibits Angiotensin\u2010II\u2010Induced Adult Mouse cardiac fibroblast proliferation and migration. AT1 physically associates with Nox4","volume":"231","author":"Somanna","year":"2016","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejphar.2026.179466_bib34","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/jcmm.17649","article-title":"Pre\u2010clinical evidence of a dual NADPH oxidase 1\/4 inhibitor (setanaxib) in liver, kidney and lung fibrosis","volume":"27","author":"Thannickal","year":"2023","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejphar.2026.179466_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102937","article-title":"Cardiomyocyte NOX4 regulates resident macrophage-mediated inflammation and diastolic dysfunction in stress cardiomyopathy","volume":"67","author":"Vendrov","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejphar.2026.179466_bib36","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1002\/ehf2.13228","article-title":"Endothelial NADPH oxidase 4 protects against angiotensin II-Induced cardiac fibrosis and inflammation","volume":"8","author":"Wang","year":"2021","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.ejphar.2026.179466_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2026.115105","article-title":"NADPH oxidase-dependent reactive oxygen species upregulate KCa3.1 to promote atrial fibroblast activation","volume":"461","author":"Wu","year":"2026","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ejphar.2026.179466_bib38","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.freeradbiomed.2026.02.014","article-title":"The autophagy receptor NDP52 recruits the E3 ligase ASB2 to mediate NOX4 degradation, suppressing cardiomyocyte ferroptosis and ameliorating heart failure","volume":"247","author":"Yang","year":"2026","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2026.179466_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101523","article-title":"NLRP3 inflammasome-mediated pyroptosis contributes to the pathogenesis of non-ischemic dilated cardiomyopathy","volume":"34","author":"Zeng","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejphar.2026.179466_bib40","doi-asserted-by":"crossref","first-page":"18121","DOI":"10.1073\/pnas.1009700107","article-title":"NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis","volume":"107","author":"Zhang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926009489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926009489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T23:15:22Z","timestamp":1793488522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926009489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":40,"alternative-id":["S0014299926009489"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179466","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resolving the dual nature of NADPH oxidase 4 in cardiac fibrosis for selective therapeutic targeting: A narrative review","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179466","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"179466"}}